The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8138347 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 20, 2012

Filed:

May. 16, 2008
Applicants:

Steven David Knight, Collegeville, PA (US);

Stanley J. Schmidt, Collegeville, PA (US);

Inventors:

Steven David Knight, Collegeville, PA (US);

Stanley J. Schmidt, Collegeville, PA (US);

Assignee:

GlaxoSmithKline LLC, Philadelphia, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 285/24 (2006.01); C07D 401/14 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
Abstract

Invented is a method of inhibiting the activity/function of PI3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives.


Find Patent Forward Citations

Knight, Steven. (2012). Quinoline derivatives as pi3 kinase inhibitors (U.S. Patent No. 8138347). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8138347

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…